Posted by Michael Wonder on 07 Oct 2022
FDA approves vaccine for use during third trimester of pregnancy to prevent whooping cough in infants younger than two months of age
7 October 2022 - Today, the US FDA approved Boostrix (Tetanus toxoid, reduced Diphtheria toxoid and acellular Pertussis vaccine, adsorbed) for immunisation during the third trimester of pregnancy to prevent pertussis, commonly known as whooping cough, in infants younger than two months of age.
Boostrix was initially approved by the FDA in 2005 as a single dose for booster immunisation against tetanus, diphtheria and pertussis in individuals 10 through 18 years of age.
